Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02195973
Title Phase IB/II Trial of LDE225 and Paclitaxel in Recurrent Ovarian Cancer
Recruitment Completed
Gender female
Phase Phase Ib/II
Variant Requirements No
Sponsors University of Alabama at Birmingham

ovary epithelial cancer

peritoneum cancer

fallopian tube carcinoma


Paclitaxel + Sonidegib

Age Groups: adult
Covered Countries USA

No variant requirements are available.